First Time Loading...

Aveo Pharmaceuticals Inc
NASDAQ:AVEO

Watchlist Manager
Aveo Pharmaceuticals Inc Logo
Aveo Pharmaceuticals Inc
NASDAQ:AVEO
Watchlist
Price: 15 USD
Updated: Apr 29, 2024

Wall Street
Price Targets

AVEO Price Targets Summary
Aveo Pharmaceuticals Inc

There are no price targets for AVEO.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Aveo Pharmaceuticals Inc Competitors:
Price Targets
ARMP
Armata Pharmaceuticals Inc
196% Upside
87S
Roivant Sciences Ltd
48% Upside
ORGO
Organogenesis Holdings Inc
110% Upside
6855
Ascentage Pharma Group International
85% Upside
OXB
Oxford BioMedica PLC
72% Upside
PBYI
Puma Biotechnology Inc
14% Downside
TSBX
Turnstone Biologics Corp
380% Upside
XBIT
XBiotech Inc
129% Upside

Revenue
Forecast

Revenue Estimate
Aveo Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for Aveo Pharmaceuticals Inc's revenue is 55%. The projected CAGR for the next 3 years is 77%.

55%
Past Growth
77%
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Aveo Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
Aveo Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-78%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AVEO's stock price target?
Not Available

AVEO doesn't have any price targets made by Wall Street professionals.

What is Aveo Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
77%

For the last 8 years the compound annual growth rate for Aveo Pharmaceuticals Inc's revenue is 55%. The projected CAGR for the next 3 years is 77%.